Brian J. Blaser
Senior Vice President, Abbott Laboratories.
Companies
- QuidelChief executive officer May 16, 2024 to now1
- QuidelPresident May 16, 2024 to now1
- Quanterix (United States)Board member Jan 9, 2023 to Jan 4, 20242
- Rockley Photonics Holdings LtdBoard member Aug 11, 2021 to Aug 30, 20223
- Talis Biomedical CorpBoard member Dec 2, 2021 to Dec 2, 20214
- Talis Biomedical CorpChief executive officer Dec 2, 2021 to Dec 2, 20214
- Talis Biomedical CorpPresident Dec 2, 2021 to Dec 2, 20214
- Abbott LaboratoriesSenior Vice President May 19, 2010 to May 24, 20195
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Abbott Laboratories ABT130,745 shares6$13.7M at $104.71May 23, 2019
Quidel QDEL75,722 shares7$964.7K at $12.74May 19, 2026
Quanterix (United States) QTRX19,049 shares8$53.1K at $2.79Jan 2, 2024- Rockley Photonics Holdings Ltd54,393 shares9May 16, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- May 15, 2026Shares withheld for tax 10,252 shares at $10.32 of Quidel7
- May 15, 2026Granted 20,759 shares of Quidel7
- Feb 13, 2026Bought 10,540 shares at $23.59 of Quidel10
- Jan 29, 2026Shares withheld for tax 7,755 shares at $27.41 of Quidel11
- Jan 29, 2026Granted 21,446 shares of Quidel11
- Nov 19, 2025Bought 23,500 shares at $21.34 of Quidel12
- May 15, 2025Shares withheld for tax 9,308 shares at $33.03 of Quidel13
- May 15, 2025Granted 20,759 shares of Quidel13
- Dec 11, 2024Bought 6,033 shares at $41.42 of Quidel14
- Jan 2, 2024Granted 2,947 shares of Quanterix (United States)8
- Jan 6, 2023Granted 16,102 shares of Quanterix (United States)15
- May 16, 2022Exercised options 7,333 shares of Rockley Photonics Holdings Ltd9
- Mar 18, 2022Bought 47,060 shares at $4.19 of Rockley Photonics Holdings Ltd16
- Mar 18, 2022Bought 47,060 shares at $4.19 of Rockley Photonics Holdings Ltd17
- May 23, 2019Sold 450,062 shares at $75.52 of Abbott Laboratories6
- May 23, 2019Exercised options 56,735 shares at $38.40 of Abbott Laboratories6
- May 23, 2019Exercised options 53,163 shares at $47.00 of Abbott Laboratories6
- May 23, 2019Exercised options 175,164 shares at $39.12 of Abbott Laboratories6
- May 23, 2019Exercised options 165,000 shares at $34.94 of Abbott Laboratories6
- Mar 1, 2019Sold 1,177 shares at $78.21 of Abbott Laboratories18
- Mar 1, 2019Sold 5,736 shares at $78.21 of Abbott Laboratories18
- Mar 1, 2019Sold 1,100 shares at $78.22 of Abbott Laboratories18
- Mar 1, 2019Sold 300 shares at $78.22 of Abbott Laboratories18
- Mar 1, 2019Sold 1,900 shares at $78.23 of Abbott Laboratories18
- Mar 1, 2019Sold 3,642 shares at $78.24 of Abbott Laboratories18
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| May 23, 2019 | ABT | Sale | $34.0M | +38.7% | +134.9% | −16.2% |
| Mar 1, 2019 | ABT | Sale | $1.3M | +33.5% | +141.8% | +6.4% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARQuidel, Chief executive officer
- 2
- 3
- 4SEC EDGARTalis Biomedical Corp, Board member
- 5
- 6
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Feb 13, 2026
- 11SEC EDGARForm 4 filed Feb 2, 2026
- 12SEC EDGARForm 4 filed Nov 20, 2025
- 13SEC EDGARForm 4 filed May 19, 2025
- 14SEC EDGARForm 4 filed Dec 13, 2024
- 15SEC EDGARForm 4 filed Jan 9, 2023
- 16SEC EDGARForm 4 filed Mar 25, 2022
- 17SEC EDGARForm 4 filed Mar 18, 2022
- 18SEC EDGARForm 4 filed Mar 4, 2019